MLL can not only activate genes by methylating H3K4 and recruiting KAT but also inhibit genes by recruiting HDACs and polycomb group (PcG) proteins.389 Recurrent mutations and fusion proteins related to MLL have been reported in various hematologic malignancies. The gene discussed is KMT2A; the disease is hematologic disorder.